Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

A panoramic review of IL-6: Structure, pathophysiological roles and inhibitors
Sukhvir Kaur, Yogita Bansal, Raj Kumar, et al.
Bioorganic & Medicinal Chemistry (2020) Vol. 28, Iss. 5, pp. 115327-115327
Closed Access | Times Cited: 340

Showing 1-25 of 340 citing articles:

Tocilizumab treatment in COVID‐19: A single center experience
Pan Luo, Yi Liu, Lin Qiu, et al.
Journal of Medical Virology (2020) Vol. 92, Iss. 7, pp. 814-818
Open Access | Times Cited: 1261
Efficacy and safety of tocilizumab in severe COVID-19 patients: a single-centre retrospective cohort study
Corrado Campochiaro, Emanuel Della‐Torre, Giulio Cavalli, et al.
European Journal of Internal Medicine (2020) Vol. 76, pp. 43-49
Open Access | Times Cited: 391
SARS-CoV-2 and COVID-19: Is interleukin-6 (IL-6) the ‘culprit lesion’ of ARDS onset? What is there besides Tocilizumab? SGP130Fc
Giuseppe Magro
Cytokine X (2020) Vol. 2, Iss. 2, pp. 100029-100029
Open Access | Times Cited: 218
Interleukin-6 in Rheumatoid Arthritis
Franco Pandolfi, Laura Franza, Valentina Carusi, et al.
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 15, pp. 5238-5238
Open Access | Times Cited: 193
The complex role of adipokines in obesity, inflammation, and autoimmunity
Erin B. Taylor
Clinical Science (2021) Vol. 135, Iss. 6, pp. 731-752
Open Access | Times Cited: 179
Interleukin-1 and interleukin-6 inhibition compared with standard management in patients with COVID-19 and hyperinflammation: a cohort study
Giulio Cavalli, Alessandro Larcher, Alessandro Tomelleri, et al.
The Lancet Rheumatology (2021) Vol. 3, Iss. 4, pp. e253-e261
Open Access | Times Cited: 169
Humanized mouse models for immuno-oncology research
Jane Chuprin, Hannah Buettner, Mina O. Seedhom, et al.
Nature Reviews Clinical Oncology (2023) Vol. 20, Iss. 3, pp. 192-206
Open Access | Times Cited: 166
The Mechanism behind Influenza Virus Cytokine Storm
Yinuo Gu, Xu Zuo, Siyu Zhang, et al.
Viruses (2021) Vol. 13, Iss. 7, pp. 1362-1362
Open Access | Times Cited: 136
IL-6 Revisited: From Rheumatoid Arthritis to CAR T Cell Therapy and COVID-19
Tadamitsu Kishimoto, Sujin Kang
Annual Review of Immunology (2022) Vol. 40, Iss. 1, pp. 323-348
Open Access | Times Cited: 91
Cisplatin-induced ototoxicity: From signaling network to therapeutic targets
Xilu Wang, Yingying Zhou, Dali Wang, et al.
Biomedicine & Pharmacotherapy (2022) Vol. 157, pp. 114045-114045
Open Access | Times Cited: 82
Effect of Induction Therapy With Olamkicept vs Placebo on Clinical Response in Patients With Active Ulcerative Colitis
Shenghong Zhang, Baili Chen, Bangmao Wang, et al.
JAMA (2023) Vol. 329, Iss. 9, pp. 725-725
Open Access | Times Cited: 59
The Role of Interleukin 6 in Periodontitis and Its Complications
Małgorzata Mazurek−Mochol, Tobias Bonsmann, Martyna Mochol, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 4, pp. 2146-2146
Open Access | Times Cited: 23
Navigating IL-6: From molecular mechanisms to therapeutic breakthroughs
Akey Krishna Swaroop, Preeya Negi, Ayushi Kar, et al.
Cytokine & Growth Factor Reviews (2024) Vol. 76, pp. 48-76
Closed Access | Times Cited: 15
Defining IL‐6 levels in healthy individuals: A meta‐analysis
Elias A. Said, Iman Al‐Reesi, Nawal Al‐Shizawi, et al.
Journal of Medical Virology (2020) Vol. 93, Iss. 6, pp. 3915-3924
Closed Access | Times Cited: 135
Comprehensive analysis of drugs to treat SARS‑CoV‑2 infection: Mechanistic insights into current COVID‑19 therapies (Review)
George Mihai Niţulescu, Horia Păunescu, Sterghios Moschos, et al.
International Journal of Molecular Medicine (2020) Vol. 46, Iss. 2, pp. 467-488
Open Access | Times Cited: 133
The bio-mission of interleukin-6 in the pathogenesis of COVID-19: A brief look at potential therapeutic tactics
Mitra Abbasifard, Hossein Khorramdelazad
Life Sciences (2020) Vol. 257, pp. 118097-118097
Open Access | Times Cited: 89
COVID‐19: Consider IL‐6 receptor antagonist for the therapy of cytokine storm syndrome in SARS‐CoV‐2 infected patients
Chiranjib Chakraborty, Ashish Ranjan Sharma, Manojit Bhattacharya, et al.
Journal of Medical Virology (2020) Vol. 92, Iss. 11, pp. 2260-2262
Open Access | Times Cited: 74
Atractylenolides, essential components of Atractylodes-based traditional herbal medicines: Antioxidant, anti-inflammatory and anticancer properties
Christian Bailly
European Journal of Pharmacology (2020) Vol. 891, pp. 173735-173735
Closed Access | Times Cited: 70
Severe delayed hypersensitivity reactions to IL-1 and IL-6 inhibitors link to common HLA-DRB1*15 alleles
Vivian E Saper, Michael J. Ombrello, Adriana H. Tremoulet, et al.
Annals of the Rheumatic Diseases (2021) Vol. 81, Iss. 3, pp. 406-415
Open Access | Times Cited: 70
Alternative Splicing: A New Cause and Potential Therapeutic Target in Autoimmune Disease
Pingping Ren, Luying Lu, Shasha Cai, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 68
The role of IL-6 in coronavirus, especially in COVID-19
Xinyi Wang, Guozheng Tang, Yuchen Liu, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 61
A Comprehensive Review about the Molecular Structure of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2): Insights into Natural Products against COVID-19
Essa M. Saied, Yousra A. El‐Maradny, Alaa A. Osman, et al.
Pharmaceutics (2021) Vol. 13, Iss. 11, pp. 1759-1759
Open Access | Times Cited: 58
Perspective for Discovery of Small Molecule IL-6 Inhibitors through Study of Structure–Activity Relationships and Molecular Docking
Hossam Nada, Aneesh Sivaraman, Qili Lu, et al.
Journal of Medicinal Chemistry (2023) Vol. 66, Iss. 7, pp. 4417-4433
Closed Access | Times Cited: 25
Effects of inflammation on myopia: evidence and potential mechanisms
Ran Xu, Jing Zheng, Longqian Liu, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 25
The dual role of interleukin-6 in Crohn’s disease pathophysiology
Ala’ Alhendi, Saleh A. Naser
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 25
Page 1 - Next Page

Scroll to top